Hybridization probe

$5.1 Billion Histology and Cytology In Vitro Diagnostics (IVD) Market, reports Kalorama Information

Retrieved on: 
Wednesday, November 30, 2022
COVID-19, Growth, IVD, Diagnosis, Cell nucleus, Elastin, Paraffin, Kidney, Cell, DNA, Histology, Tissue, Congo red, Fluid mechanics, Hybridization probe, Enzyme, H&E, Virulence, PAS, Physician, Organic acid, Protein, In situ hybridization, Fiber, FISH, COVID, Cancer, HPV, ISH, Sputum, Therapy, Cytoplasm, Immunohistochemistry, Marie Cassidy, Iron, IHC, Liver, HIV disease progression rates, Medical imaging, Microscope, Ralph E. Gomory

ARLINGTON, Va., Nov. 30, 2022 /PRNewswire-PRWeb/ -- 

Key Points: 
  • The market for the testing of tissues and cells, histology and cytology in vitro diagnostics reached $4.9 billion in 2021 per market research firm Kalorama Information and is expected to grow to $5.1 billion in 2022.
  • The global histology IVD market grew 23.5% from 2020 to 2021 reflecting strong rebounding after the market experienced negative effects from the COVID-19 pandemic during 2020.
  • The market stabilized from COVID and now Kalorama Information analysts expect a 4.2% CAGR.
  • All of these techniques involve analyzing cells either in surgical and biopsied tissue (histology) or body fluids (cytology).

Global Nanomedicine Market Report to 2027 - by Nanomolecule Type, Nanoparticles Type, Application, Disease Indication and Region - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 19, 2022
Biotechnology, Pharmaceutical, Health, Research, Conditional sentence, Nanoshell, Cancer, Application, Degenerative disease, Solution, CAGR, DNA, Dementia, Metabolism, Hybridization probe, Diabetes, Regenerative medicine, Nanomedicine, Nano, Google Images, Prevalence, Globe, Vaccine, Awareness, Medical imaging, Pharmaceutical industry, Nanoparticle, Carbon nanotube, Nanotechnology

The "Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type, By Application, By Disease Indication, By Region and Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type, By Application, By Disease Indication, By Region and Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.
  • The Global Nanomedicine Market is expected to grow at an impressive CAGR of 8.28% in the forecast period, 2023-2027, to reach USD242,655.19 million by 2027.
  • However, the high cost associated with the nanomedicine manufacturing process and research and development activities may hinder the Global Nanomedicine Market in the forecast period.
  • The Global Nanomedicine Market is divided into nano molecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape.

French Defense Innovation Agency Investigates the Use of DNA Script’s SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats

Retrieved on: 
Tuesday, June 28, 2022
Science, Biotechnology, Defense, Research, Health, Infectious Diseases, Genetics, Government Technology, Hybridization probe, Enzyme, View, Weapon, CEO, Research, Armed Forces DNA Identification Laboratory, EDS, DGA, Organic acid, Partnership, Technology, Military, DNA, Real-time, SYNTAX, Infection, Fine chemical

DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the first successful qPCR assays using primers and probes synthesized by a customer via enzymatic synthesis using the companys SYNTAX System DNA printer.

Key Points: 
  • DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the first successful qPCR assays using primers and probes synthesized by a customer via enzymatic synthesis using the companys SYNTAX System DNA printer.
  • This success was achieved as part of a contract with the French Defense Innovation Agency, in liaison with the French Armament General Directorate (DGA), first announced in January 2021.
  • The partnership leverages the SYNTAX System to produce high-quality DNA primers and probes to rapidly develop qPCR assays for infectious disease detection.
  • This extension validates the importance of our SYNTAX benchtop DNA printing system for rapid response programs, said Thomas Ybert, CEO and co-founder of DNA Script.

Nanomedicine Market to reach US$ 512.47 billion by 2028, Says TMR

Retrieved on: 
Friday, March 4, 2022
Diagnosis, Degenerative disease, Conditional sentence, Nanocarriers, Dementia, Molecular imaging, DNA, Particle-size distribution, Growth, Nanomedicine, Consistency, Nanotechnology, Adoption, Metabolism, Cancer, Neoplasm, CAGR, Nanosensor, Diabetes, Nanoparticle, Hybridization probe, MRI, Medical imaging, Vaccine

Consistent R&D in nanomedicine with the need to identify and exploit the full potential of current technologies for nanomedicine such as nanoparticles, nanocarriers, and nanosensors is anticipated to create monumental opportunities in nanomedicine market .

Key Points: 
  • Consistent R&D in nanomedicine with the need to identify and exploit the full potential of current technologies for nanomedicine such as nanoparticles, nanocarriers, and nanosensors is anticipated to create monumental opportunities in nanomedicine market .
  • Nanomedicine technologies such as nanoparticle based diagnostic agents, targeted drug delivery, and conjugated drug nanoparticles currently find an array of medical applications.
  • Prospects of development of new technologies such as molecular nanotechnology, nanorobots, and nanovaccinology to open up new application areas of nanomedicine will stimulate the growth of nanomedicine market.
  • Several medical applications of nanomedicine in the diagnosis, treatment, monitoring, and control of biological systems for improved medicine drug delivery, which involves manipulating materials on nanoscale fuel the growth of nanomedicine market
    Some of the key players operating in the nanomedicine market are;

Nanomedicine Market to reach US$ 512.47 billion by 2028, Says TMR

Retrieved on: 
Friday, March 4, 2022
Diagnosis, Degenerative disease, Conditional sentence, Nanocarriers, Dementia, Molecular imaging, DNA, Particle-size distribution, Growth, Nanomedicine, Consistency, Nanotechnology, Adoption, Metabolism, Cancer, Neoplasm, CAGR, Nanosensor, Diabetes, Nanoparticle, Hybridization probe, MRI, Medical imaging, Vaccine

ALBANY, N.Y., March 4, 2022 /PRNewswire/ -- The nanomedicine market is estimated to expand at a CAGR of 12.6% for the forecast period from 2021 to 2028. Consistent R&D in nanomedicine with the need to identify and exploit the full potential of current technologies for nanomedicine such as nanoparticles, nanocarriers, and nanosensors is anticipated to create monumental opportunities in nanomedicine market.

Key Points: 
  • Consistent R&D in nanomedicine with the need to identify and exploit the full potential of current technologies for nanomedicine such as nanoparticles, nanocarriers, and nanosensors is anticipated to create monumental opportunities in nanomedicine market .
  • Nanomedicine technologies such as nanoparticle based diagnostic agents, targeted drug delivery, and conjugated drug nanoparticles currently find an array of medical applications.
  • Prospects of development of new technologies such as molecular nanotechnology, nanorobots, and nanovaccinology to open up new application areas of nanomedicine will stimulate the growth of nanomedicine market.
  • Several medical applications of nanomedicine in the diagnosis, treatment, monitoring, and control of biological systems for improved medicine drug delivery, which involves manipulating materials on nanoscale fuel the growth of nanomedicine market
    Some of the key players operating in the nanomedicine market are;

Global Cytogenetics Markets, Technology, & Competitive Landscape Report 2021 with Profiles of 70 Companies - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 18, 2021
Technology, Biotechnology, Nanotechnology, Health, CGH, Chromosome, Fort Dix, Single-nucleotide polymorphism, Optical flow, Technology, Magnetic resonance imaging, Biomarker, FISH, PCR, Diagnosis, Disease, SWOT, Nanotechnology, Cancer, SPM, AFM, Human, Fluorescence, Therapy, PNA, Genetic variation, Molecular imaging, Lists of diseases, Hybridization probe, DNA, Organic acid, Infection, MRI, Optical mapping, PET, In situ hybridization, Drug discovery, Company, Genetic disorder, Real-time polymerase chain reaction, Comparative genomic hybridization, Pharmaceutical industry, Medical imaging, Microscope

This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease.

Key Points: 
  • This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease.
  • The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.
  • Molecular cytogenetics includes the applications of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection.
  • The report includes summary profiles of 70 companies relevant to cytogenetics along with their 80 collaborations.

Twist Bioscience Expands Expert Custom Alliance Panel Offering

Retrieved on: 
Tuesday, October 5, 2021
Oncology, Health, Genetics, Research, Science, Biotechnology, Well, Cancer, NGS, Partnership, Risk, Security (finance), Collection, Workflow, Sale, Private Securities Litigation Reform Act, NASDAQ, DNA, Doctor of Philosophy, U.S. Securities and Exchange Commission, Engineering, Population, Martek Biosciences Corporation, TCGA, Twist Bioscience, Gene, Biology, RGC, CEO, Sequence, Genomics, DNA methylation, Knowledge, Agriculture, The Cancer Genome Atlas, Large-cell lung carcinoma, Technology, Â, Research, Hybridization probe, Silicon, Colorectal cancer, Synthetic biology, Drug discovery, Breast cancer, SEC, Database, Fine chemical, Twist Alliance Panels, Twist Bioscience Corporation, TWIST ALLIANCE PANELS, TWIST BIOSCIENCE CORPORATION

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an expansion of its expert-led Alliance Panel product offering.

Key Points: 
  • Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an expansion of its expert-led Alliance Panel product offering.
  • Designed through collaboration with world-leading experts, Twist Alliance Panels combine validated content with Twist next-generation sequencing (NGS) workflow, target enrichment and DNA probes.
  • As the first Alliance Panel offering, Twist collaborated with the Regeneron Genetics Center LLC (RGC), a wholly-owned subsidiary of Regeneron, to develop the Twist Diversity SNP Panel , a custom NGS population genetics genotyping assay available to researchers globally for population genomics studies.
  • Today, Twist and AnchorDx launched the Twist Alliance Pan-cancer Methylation Panel based on The Cancer Genome Atlas (TCGA) database, including 31 cancer types and 47 TCGA database disease entities.

Fluorescent in Situ Hybridization (FISH) Probe Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2014-2019 & 2020-2024 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 15, 2020
Health, Genetics, Branches of biology, Biology, Molecular biology, Laboratory techniques, Cytogenetics, In situ hybridization, Fluorescence in situ hybridization, Nucleic acid hybridization, Hybridization probe, Riboprobe

The "Fluorescent in Situ Hybridization (FISH) Probe Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fluorescent in Situ Hybridization (FISH) Probe Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • Looking forward,, the publisher expects the global fluorescence in situ hybridization (FISH) probe market to continue its moderate growth during the next five years.
  • What has been the impact of COVID-19 on the global fluorescence in situ hybridization (FISH) probe market?
  • What is the structure of the global fluorescence in situ hybridization (FISH) probe market and who are the key players?

Japan Nucleic Acid Testing/NAT Market for 100 Assays: 2019 Report - Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 30, 2019
Biotechnology, Genetics, Health, Natural sciences, Molecular biology, Chemistry, Physical sciences, Laboratory techniques, Medical diagnosis, Nucleic acid test, Hybridization probe, Assay

The "Japan Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Japan Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

2019 U.S. Nucleic Acid Testing/NAT Market - Sales and Market Shares of Key Suppliers - ResearchAndMarkets.com

Retrieved on: 
Monday, October 14, 2019
Health, Biotechnology, Molecular biology, Medical diagnosis, Nucleic acid test, Hybridization probe, Market share, Academic disciplines

The "U.S. Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Sales and market shares of leading suppliers.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.